Joshua O. Benditt

Joshua Benditt practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Joshua Benditt's NPI, 1154406981, was assigned on October 27, 2006. Joshua Benditt graduated from University Of Washington School Of Medicine in 1982. Joshua Benditt holds Washington license MD00031466.

Joshua Benditt's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Joshua Benditt's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Joshua Benditt to 1 more hospital, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Joshua Benditt practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Joshua Benditt's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Joshua Benditt is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Joshua Benditt's licenses on file in 2 states: Washington and Rhode Island.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD) and chronic respiratory failure among the conditions Joshua Benditt treats.

CMS data shows 602 Medicare services from Joshua Benditt across 11 procedure codes in 2024, for 298 Medicare patients. Medicare paid $26,726 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 298 Medicare patients who saw Joshua Benditt in 2024. The largest group is 65 to 74, with 128 patients. 65% of them have high blood pressure, and 61% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Joshua Benditt's median patient age at 58, with 52% women.

In 2024, Joshua Benditt wrote 158 Medicare Part D claims for 27 patients. 68% of them were for generic drugs. CMS names the drug for 96 of them, across 5 drugs with 11 or more claims each, at $7,403 in total drug cost. In 2023, CMS named 98 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Joshua Benditt for performance year 2024, reported through an alternative payment model (APM). Joshua Benditt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Joshua Benditt as offering telehealth.

Dmand AI links 60 papers to Joshua Benditt, published from 2005 to 2023. 2021 was the busiest year, with 5. The most frequent topics are Muscular Dystrophy, Duchenne, Neuromuscular Diseases and Dyspnea. Joshua Benditt has published most often in Am J Respir Crit Care Med. Joshua Benditt's most frequent co-authors are David J. Birnkrant, MD, Richard M. Kravitz, MD and Jonathan D. Finder, MD.

CMS Open Payments shows 2 general payments to Joshua Benditt from 2 drug and device companies from 2017 to 2020. Consulting fees make up the largest share, 95% of the total. Ventec Life Systems, Inc. paid the most, $2,500.

Dmand AI lists 1 award for Joshua Benditt.

Joshua Benditt graduated from University Of Washington School Of Medicine in 1982.

Joshua Benditt is in network with 11 carriers, including Aetna, United Healthcare and Humana. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.